3Berqvist A.Different types of extragenital endometriosis:a review.Gynecol Endocrinol,1993,207(3):207.
4Patterson GK,Winburn GB.Abdominial wall endometriomas:report of eight cases.Am Surg,1999,65:36～39.
5Gasparini G.Harris A.Clinical importance of Tumur angiogenesis in breast carcinoma much more than a new prognostic too.J Clin onco.1995.13:765.
6Muchmore SW, Chen J, Jakob C, et al. Crystal structure and mutagenic analysis of the inhibitor of apoptosis protein survivin [ J ]. Mol Cell ,2000,6 ( 1 ) : 173 - 182.
7Krieg A, Mahotka C, Krieg T,et al. Gerharz CD. Expression of different survivin variants in gastric carcinomas first clues to a role of surviving- 2B in tumour progression[ J ]. British Journal of Cancer, 2002, 86 (5) :737 - 743.
8Skoufias DA, Mollinari C, Lacroux FB, et al. Human surviving is a kinetochore - associated passenger protein[ J]. J Cell Biol, 2000, 15 (7) : 1575 - 1582.
9Suzuki A, Hayashida M, Ito T ,et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16NK4aand Cdk2/Cyclin E complex activation [ J ]. Oncogene ,2000,19 ( 29 ) :3225 - 3234.
10Suzuki A, Ito T, Kawano H , et al. Survivin initiates pro - caspase3/ p21 complex formation as a result of interaction with Cdk4 to resist Fas - mediated cell death [ J ]. Oncogene,2000,19 (10) : 1346.
